News for 'CY26'

Valuation a key hurdle for auto stocks in short term

Valuation a key hurdle for auto stocks in short term

Rediff.com24 Sep 2025

Multiple tailwinds for the automobile sector, including a cut in goods and services tax (GST) rates, are keeping analysts bullish on auto stocks from a long-term perspective, even as they see the rally running its course in the near term.

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

Rediff.com8 Aug 2025

The US' move to raise the tariff on most Indian goods to 50 per cent could drag India's GDP growth for FY26 by 35 to 60 basis points, according to various economists. One basis point (bp) is equal to 0.01 per cent.

Jio's Rs 30,000 Cr IPO: India's Largest

Jio's Rs 30,000 Cr IPO: India's Largest

Rediff.com2 Sep 2025

Reliance holds 67.03% of Jio Platforms Limited and the public listing would provide an exit to many investors.

Why brokerages are bullish on Hindalco

Why brokerages are bullish on Hindalco

Rediff.com29 May 2025

Hindalco's India business, including Utkal Alumina, reported good results for the January-March quarter of the financial year 2024-25 (FY25) and consolidated earnings before interest, taxes, depreciation, and amortisation (Ebitda) also rose. Earnings growth was driven by favourable pricing, lower input costs and lower tax outgo for Novelis.

Surge in e2W Launches Sparks Fierce Price Battle

Surge in e2W Launches Sparks Fierce Price Battle

Rediff.com17 Mar 2025

From premium electric motorcycles to mass-market scooters, manufacturers are rapidly expanding their portfolios to capture a larger share of the booming market.

Novelis expects improved outlook in near term, Q4FY25 to outperform Q3

Novelis expects improved outlook in near term, Q4FY25 to outperform Q3

Rediff.com25 Feb 2025

Novelis' Q3FY25 volume stood at 904,000 tonnes (down 1 per cent Y-o-Y, down 4 per cent Q-o-Q), due to lower VAP and automotive shipments. Revenue stood at $4.1 billion (+4 per cent Y-o-Y, down 5 per cent Q-o-Q).

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Rediff.com8 Jul 2024

Dr Reddy's Laboratories (DRL) is set to acquire Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US. DRL will pay a total consideration of 500 million, including an upfront cash consideration of 458 million and contingent cash payments up to 42 million based on performances in CY25 and CY26. DRL will acquire the portfolio through the purchase of shares of Northstar Switzerland SARL, a Haleon group firm.

Analysts hopeful for Hindalco despite Novelis' capex revised upwards

Analysts hopeful for Hindalco despite Novelis' capex revised upwards

Rediff.com22 Feb 2024

In the October-December quarter (Q3) of FY24, Hindalco reported flat consolidated revenue year-on-year (Y-o-Y) at Rs 52,800 crore. Copper revenue rose due to higher shipments and better Average Selling Price (ASP). Revenue from the aluminium vertical and Novelis declined 3 per cent and 6 per cent Y-o-Y, respectively.

Potential for Indian IT stocks likely to see some rerating

Potential for Indian IT stocks likely to see some rerating

Rediff.com12 Sep 2023

After disappointing guidances in the first quarter (Apr-Jun) of the 2023-24 financial year (Q1FY24) and valuation downgrades, the Indian IT sector could see some positive repricing as the bad news for IT maybe easing in Q2FY24. A key negative factor was weaker demand from the US financial sector and from North America in general. The latest GDP (gross domestic product) estimates and sector-specific news suggest that the demand situation may not be quite so bad with a gradual recovery in tech spending in Q2.

« Prev  |